Atom | Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

Due Dates: September 16, 2025 (single-stage)

Funding Amounts: ~€10 million per project; total call budget €50 million; up to 5 projects funded; lump sum grants

Summary: Supports R&D of antibody and antibody-derived proteins for prevention and treatment of epidemic-prone viral diseases, from preclinical to first-in-human clinical studies.

Key Information: Focus on priority viruses; clinical studies required; SMEs/start-ups encouraged; international partners eligible.

Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

Sign in to see full grant listing